High dosage of Rosuvastatin demonstratesrobust lowering of TG levels in high risk patients
Rosuvastatin demonstrates reduction in HF Hospitalization & small reduction in MI as per controlled multinational trials in heart failure (CORONA) & GISSI – HF trials